Leukemia following chemotherapy for breast cancer.

Abstract:

:Leukemia following chemotherapy for breast cancer was studied among patients diagnosed during 1973-1985 within the population-based tumor registries in the Surveillance, Epidemiology, and End Results Program. Among 13,734 women given initial chemotherapy, 24 developed acute nonlymphocytic leukemia (ANLL) compared to 2.1 expected based on general population rates (observed/expected = 11.5; 95% confidence interval = 7.4-17.1). Overall, 58 excess ANLL occurred per 100,000 women-years at risk for patients treated with chemotherapy. The cumulative incidence was 0.7% at 10 years. Risk remained high over all periods of observation up to 9 years after treatment. Among 7974 women treated only with surgery during 1973 and 1974, a period before the widespread use of adjuvant chemotherapy for breast cancer, ANLL was not significantly increased (observed = 7, expected = 5.1). A case-control study was then conducted in Connecticut to evaluate in more detail the risk associated with adjuvant chemotherapy in the general population. Among 20 cases (17 incident leukemias and 3 deaths due to preleukemia) and 60 matched controls, alkylating agents were linked to an 11.9-fold risk of ANLL and preleukemia (95% confidence interval = 2.6-55). Chemotherapy regimens including melphalan were related to a higher risk of leukemic conditions than those including cyclophosphamide. These data suggest that women in the general population treated with adjuvant chemotherapy for breast cancer are at an increased risk of leukemia, that the risk remains high among long-term survivors, and that risk differs by type of alkylating agent administered.

journal_name

Cancer Res

journal_title

Cancer research

authors

Curtis RE,Boice JD Jr,Moloney WC,Ries LG,Flannery JT

subject

Has Abstract

pub_date

1990-05-01 00:00:00

pages

2741-6

issue

9

eissn

0008-5472

issn

1538-7445

journal_volume

50

pub_type

杂志文章
  • Human enhancer of filamentation 1 Is a mediator of hypoxia-inducible factor-1alpha-mediated migration in colorectal carcinoma cells.

    abstract::Human enhancer of filamentation 1 (HEF1; also known as NEDD9 or Cas-L) is a scaffolding protein that is implicated in regulating diverse cellular processes, such as cellular attachment, motility, cell cycle progression, apoptosis, and inflammation. Here, we identify HEF1 as a novel hypoxia-inducible factor-1alpha (HIF...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-2110

    authors: Kim SH,Xia D,Kim SW,Holla V,Menter DG,Dubois RN

    更新日期:2010-05-15 00:00:00

  • Phase I study of 2'-deoxycoformycin in acute lymphoblastic leukemia.

    abstract::2'-Deoxycoformycin (2'-dCF), a tight-binding inhibitor of adenosine deaminase, was administered to 26 pediatric patients with acute lymphoblastic leukemia in a Phase I study. Doses ranged from 0.25 to 1.0 mg/kg given i.v. for 3 consecutive days. Common toxicity included nausea, vomiting, diarrhea, hepatocellular enzym...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Poplack DG,Sallan SE,Rivera G,Holcenberg J,Murphy SB,Blatt J,Lipton JM,Venner P,Glaubiger DL,Ungerleider R,Johns D

    更新日期:1981-09-01 00:00:00

  • Assessment of protein kinase C isozymes by enzyme immunoassay and overexpression of type II in thyroid adenocarcinoma.

    abstract::A two site enzyme immunoassay which quantitatively identifies types I, II, and III of protein kinase C isozymes has been designed. The soluble protein kinase C isozymes were selectively immobilized by type-specific monoclonal antibodies, MC-1a, -2a, and -3a (H. Hidaka et al., J Biol. Chem., 263: 4523-4526, 1988) which...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hagiwara M,Hachiya T,Watanabe M,Usuda N,Iida F,Tamai K,Hidaka H

    更新日期:1990-09-01 00:00:00

  • Pathogenesis of ascites tumor growth: fibrinogen influx and fibrin accumulation in tissues lining the peritoneal cavity.

    abstract::In the immediately preceding paper, we demonstrated that the microvasculature supplying peritoneal lining tissues of mice bearing either of two transplantable ascites carcinomas was hyperpermeable to circulating macromolecules. Solid tumors have been shown to exhibit similar levels of microvascular hyperpermeability, ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Nagy JA,Meyers MS,Masse EM,Herzberg KT,Dvorak HF

    更新日期:1995-01-15 00:00:00

  • Efficient oncolysis by a replicating adenovirus (ad) in vivo is critically dependent on tumor expression of primary ad receptors.

    abstract::Replicating adenoviruses (Ads) are designed to replicate in and destroy cancer cells, generating viral progeny that spread within the tumor. To address the importance of the primary cellular receptor for Ads, the coxsackievirus and Ad receptor (CAR), in permitting intratumoral spread of a replicating Ad, we have used ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Douglas JT,Kim M,Sumerel LA,Carey DE,Curiel DT

    更新日期:2001-02-01 00:00:00

  • Abrogation of c-kit/Steel factor-dependent tumorigenesis by kinase defective mutants of the c-kit receptor: c-kit kinase defective mutants as candidate tools for cancer gene therapy.

    abstract::The growth and survival of many types of cancer cells are known to be supported by specific growth factor/cytokine systems. Among these, the activation of c-kit receptor and its ligand steel factor participates in several types of human carcinogenesis. W mutations of laboratory mouse strains are loss of functional mut...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Li Q,Kondoh G,Inafuku S,Nishimune Y,Hakura A

    更新日期:1996-10-01 00:00:00

  • Inflammasome Adaptor ASC Suppresses Apoptosis of Gastric Cancer Cells by an IL18-Mediated Inflammation-Independent Mechanism.

    abstract::Inflammasomes are key regulators of innate immunity in chronic inflammatory disorders and autoimmune diseases, but their role in inflammation-associated tumorigenesis remains ill-defined. Here we reveal a protumorigenic role in gastric cancer for the key inflammasome adaptor apoptosis-related speck-like protein contai...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-17-1887

    authors: Deswaerte V,Nguyen P,West A,Browning AF,Yu L,Ruwanpura SM,Balic J,Livis T,Girard C,Preaudet A,Oshima H,Fung KY,Tye H,Najdovska M,Ernst M,Oshima M,Gabay C,Putoczki T,Jenkins BJ

    更新日期:2018-03-01 00:00:00

  • p21 Waf1/Cip1 expression by curcumin in U-87MG human glioma cells: role of early growth response-1 expression.

    abstract::Curcumin, a natural compound, is a well-known chemopreventive agent with potent anticarcinogenic activity in a wide variety of tumor cells. Curcumin inhibits cancer cell proliferation in part by suppressing cyclin D1 and inducing expression of the cyclin-dependent kinase inhibitor p21(Waf1/Cip1). Both p53-dependent an...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-5222

    authors: Choi BH,Kim CG,Bae YS,Lim Y,Lee YH,Shin SY

    更新日期:2008-03-01 00:00:00

  • Interaction between p53 mutation and a somatic HDMX biomarker better defines metastatic potential in breast cancer.

    abstract::TP53 gene mutation is associated with poor prognosis in breast cancer, but additional biomarkers that can further refine the impact of the p53 pathway are needed to achieve clinical utility. In this study, we evaluated a role for the HDMX-S/FL ratio as one such biomarker, based on its association with other suppressor...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-14-2637

    authors: Grawenda AM,Møller EK,Lam S,Repapi E,Teunisse AF,Alnæs GI,Børresen-Dale AL,Kristensen VN,Goding CR,Jochemsen AG,Edvardsen H,Bond GL

    更新日期:2015-02-15 00:00:00

  • Unraveling the "known unknowns": lessons and reflections from the new directions in leukemia research 2012 conference.

    abstract::Patients diagnosed with leukemia approach their treatment with the hope of cure despite the effect on their quality of life. Some patients will be cured, others will die from treatment, and some will die of their disease. A common theme at the New Directions in Leukemia Research (NDLR 2012) meeting was that cure will ...

    journal_title:Cancer research

    pub_type:

    doi:10.1158/0008-5472.CAN-12-1832

    authors: White DL,Brown AL,D'Andrea RJ,Rice AM

    更新日期:2012-09-01 00:00:00

  • Immunotoxin-mediated inhibition of chronic lymphocytic leukemia cell proliferation in humans.

    abstract::We evaluated the cytotoxicity of the immunotoxin OKT1-SAP on fresh B-chronic lymphocytic leukemia (B-CLL) cells from 31 consecutive patients. OKT1-SAP comprised the OKT1 (CD5) monoclonal antibody disulfide linked to saporin-6 (SAP) ribosome-inactivating protein from the plant Saponaria officinalis. The effect of OKT1-...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Siena S,Bregni M,Formosa A,Brando B,Marenco P,Lappi DA,Bonadonna G,Gianni AM

    更新日期:1989-06-15 00:00:00

  • Development of polyploidization in taxol-resistant human leukemia cells in vitro.

    abstract::The effects of taxol on antitubulin immunofluorescent staining patterns, cellular DNA content, and labeling with [3H]thymidine were measured for the taxol-sensitive HL60 and taxol-resistant K562 cell lines after exposures for 0, 4, 12, and 24 h. Taxol caused a relative increase in the fraction of 4C interphase and met...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Roberts JR,Allison DC,Donehower RC,Rowinsky EK

    更新日期:1990-02-01 00:00:00

  • Siah proteins: novel drug targets in the Ras and hypoxia pathways.

    abstract::The Siah (seven in absentia homolog) family of RING-domain proteins are components of ubiquitin ligase complexes, targeting proteins for proteasomal degradation. Siah family members have been reported to function in Ras, estrogen, DNA-damage, and hypoxia response pathways. Although earlier reports implicated Siah prot...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-09-1676

    authors: House CM,Möller A,Bowtell DD

    更新日期:2009-12-01 00:00:00

  • Metallothionein localization and cisplatin resistance in human hormone-independent prostatic tumor cell lines.

    abstract::Metallothioneins (MT) are major cysteine-rich proteins with poorly characterized functions. We have examined the MT amount, isotype expression, and subcellular distribution in 4 human hormone-independent prostatic carcinoma cell lines. Both PC-3 and DU-145 cells were thiol-rich cells with similar MT and glutathione le...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kondo Y,Kuo SM,Watkins SC,Lazo JS

    更新日期:1995-02-01 00:00:00

  • Biological and karyotypic characterization of a new cell line derived from human gliosarcoma.

    abstract::A cell line (NCE-G28) was established from the biopsy material of a human gliosarcoma of low histological differentiation. The initial cultures showed a mixed population of cells which in later stages became more uniform due to loss of slower growing constituents. The cells have been growing steadily for 20 months. A ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Westphal M,Haensel M,Mueller D,Laas R,Kunzmann R,Rohde E,Koenig A,Hoelzel F,Herrmann HD

    更新日期:1988-02-01 00:00:00

  • Identification of the MEK1(F129L) activating mutation as a potential mechanism of acquired resistance to MEK inhibition in human cancers carrying the B-RafV600E mutation.

    abstract::Although targeting the Ras/Raf/MEK pathway remains a promising anticancer strategy, mitogen-activated protein/extracellular signal-regulated kinase (ERK) kinase (MEK) inhibitors in clinical development are likely to be limited in their ability to produce durable clinical responses due to the emergence of acquired drug...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-4351

    authors: Wang H,Daouti S,Li WH,Wen Y,Rizzo C,Higgins B,Packman K,Rosen N,Boylan JF,Heimbrook D,Niu H

    更新日期:2011-08-15 00:00:00

  • The N-hydroxy metabolites of N-methyl-4-aminoazobenzene and related dyes as proximate carcinogens in the rat and mouse.

    abstract::The carcinogenicities for rats and mice of N-methyl-4-aminoazobenzene (MAB) and its hepatic microsomal metabolite N-hydroxy-N-methyl-4-aminoazobenzene (N-hydroxy-MAB) were compared under several conditions. N-Ethyl-4-aminoazobenzene, 4-aminoazobenzene, and their N-hydroxy derivatives were also included in some of the ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Miller EC,Kadlubar FF,Miller JA,Pitot HC,Drinkwater NR

    更新日期:1979-09-01 00:00:00

  • Manipulation of oxygen radical-scavenging capacity in mice alters host sensitivity to tumor necrosis factor toxicity but does not interfere with its antitumor efficacy.

    abstract::The role of oxygen free radicals in the toxicity and antitumor effect of tumor necrosis factor was investigated in vivo. Treatment of non-tumor-bearing mice and mice bearing methylcholanthrene-induced sarcomas with bovine CuZn superoxide dismutase or recombinant human CuZn superoxide dismutase afforded significant pro...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hauser GJ,McIntosh JK,Travis WD,Rosenberg SA

    更新日期:1990-06-15 00:00:00

  • Activating Mutations in PIK3CB Confer Resistance to PI3K Inhibition and Define a Novel Oncogenic Role for p110β.

    abstract::Activation of the PI3K pathway occurs commonly in a wide variety of cancers. Experience with other successful targeted agents suggests that clinical resistance is likely to arise and may reduce the durability of clinical benefit. Here, we sought to understand mechanisms underlying resistance to PI3K inhibition in PTEN...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-15-2201

    authors: Nakanishi Y,Walter K,Spoerke JM,O'Brien C,Huw LY,Hampton GM,Lackner MR

    更新日期:2016-03-01 00:00:00

  • Stimulation of tumor necrosis factor release from monocytic cells by the A375 human melanoma via granulocyte-macrophage colony-stimulating factor.

    abstract::It has long been known that complex interactions occur between tumors and normal host immune cells. The human melanoma cell line A375 has been used previously as an indicator cell for tumor cell cytotoxicity mediated by monocytes. During other studies on this tumor cell line, we noted that the conditioned media harves...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Sabatini M,Chavez J,Mundy GR,Bonewald LF

    更新日期:1990-05-01 00:00:00

  • Truncated DNMT3B isoform DNMT3B7 suppresses growth, induces differentiation, and alters DNA methylation in human neuroblastoma.

    abstract::Epigenetic changes in pediatric neuroblastoma may contribute to the aggressive pathophysiology of this disease, but little is known about the basis for such changes. In this study, we examined a role for the DNA methyltransferase DNMT3B, in particular, the truncated isoform DNMT3B7, which is generated frequently in ca...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-12-0886

    authors: Ostler KR,Yang Q,Looney TJ,Zhang L,Vasanthakumar A,Tian Y,Kocherginsky M,Raimondi SL,DeMaio JG,Salwen HR,Gu S,Chlenski A,Naranjo A,Gill A,Peddinti R,Lahn BT,Cohn SL,Godley LA

    更新日期:2012-09-15 00:00:00

  • In vivo radiolocalization of antiosteogenic sarcoma monoclonal antibodies in osteogenic sarcoma xenografts.

    abstract::Monoclonal antibodies Ost6 and Ost7 (mouse Immunoglobulin G1) to human osteogenic sarcoma were isolated from ascitic fluid and labeled with radioiodine. After injection into athymic nu/nu mice with s.c. xenografts of human osteogenic sarcoma, the uptake of radioactivity in tumors, visceral organs, and blood was determ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Nakamura T,Sakahara H,Hosoi S,Yamamuro T,Higashi S,Mikawa H,Endo K,Toyama S

    更新日期:1984-05-01 00:00:00

  • Comparative structure-genotoxicity study of three aminoanthraquinone drugs and doxorubicin.

    abstract::Two aminoanthraquinone analogs 1,4-bis(2-[(2-hydroxyethyl)amino]ethylamino)-9,10-anthracenedione (HAQ) and 1,4-dihydroxy-5,8-bis(2-[(2-hydroxyethyl)amino]ethylamino]-9,10-anthracenedione (DHAQ) have been shown to possess similar therapeutic activities against experimental tumors but different toxicities to the animal...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Au WW,Butler MA,Matney TS,Loo TL

    更新日期:1981-02-01 00:00:00

  • TGF-β modulates ovarian cancer invasion by upregulating CAF-derived versican in the tumor microenvironment.

    abstract::TGF-β has limited effects on ovarian cancer cells, but its contributions to ovarian tumor growth might be mediated through elements of the tumor microenvironment. In the present study, we tested the hypothesis that TGF modulates ovarian cancer progression by modulating the contribution of cancer-associated fibroblasts...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-0023

    authors: Yeung TL,Leung CS,Wong KK,Samimi G,Thompson MS,Liu J,Zaid TM,Ghosh S,Birrer MJ,Mok SC

    更新日期:2013-08-15 00:00:00

  • Phosphorylation of ribosomal protein S6 attenuates DNA damage and tumor suppression during development of pancreatic cancer.

    abstract::The signaling pathways that mediate the development of pancreatic ductal adenocarcinoma (PDAC) downstream of mutant Kras remain incompletely understood. Here, we focus on ribosomal protein S6 (rpS6), an mTOR effector not implicated previously in cancer. Phosphorylation of rpS6 was increased in pancreatic acinar cells ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-12-2014

    authors: Khalaileh A,Dreazen A,Khatib A,Apel R,Swisa A,Kidess-Bassir N,Maitra A,Meyuhas O,Dor Y,Zamir G

    更新日期:2013-03-15 00:00:00

  • Factors affecting growth and drug sensitivity of mouse mammary tumor lines in collagen gel cultures.

    abstract::A series of mouse mammary tumor subpopulation lines were compared for growth properties and sensitivity to chemotherapeutic drugs when grown as boluses in a collagen gel matrix versus in monolayer culture. Although the cell lines exhibited characteristic rates of bolus expansion in collagen, this growth was not parall...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Miller BE,Miller FR,Heppner GH

    更新日期:1985-09-01 00:00:00

  • A carcinofetal antigen located on the membrane of cells from rat intestinal carcinoma in culture.

    abstract::Heteroantisera were produced in rabbits by immunization with cultivated cells from rat intestinal carcinomas. The sera were made specific by in vivo absorption in syngeneic rats. On immunofluorescence, these sera recognized a membrane-associated antigen common to five different intestinal carcinomas and to fetal intes...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Martin F,Knobel S,Martin M,Bordes M

    更新日期:1975-02-01 00:00:00

  • Stromal SNAI2 Is Required for ERBB2 Breast Cancer Progression.

    abstract::SNAI2 overexpression appears to be associated with poor prognosis in breast cancer, yet it remains unclear in which breast cancer subtypes this occurs. Here we show that excess SNAI2 is associated with a poor prognosis of luminal B HER2+/ERBB2+ breast cancers in which SNAI2 expression in the stroma but not the epithel...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-20-0278

    authors: Blanco-Gómez A,Hontecillas-Prieto L,Corchado-Cobos R,García-Sancha N,Salvador N,Castellanos-Martín A,Sáez-Freire MDM,Mendiburu-Eliçabe M,Alonso-López D,De Las Rivas J,Lorente M,García-Casas A,Del Carmen S,Abad-Hernández MDM,C

    更新日期:2020-12-01 00:00:00

  • Down-regulation of androgen receptor by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells.

    abstract::Despite the initial efficacy of androgen deprivation therapy, most patients with advanced prostate cancer eventually progress to hormone-refractory prostate cancer, for which there is no curative therapy. Previous studies from our laboratory and others have shown the antiproliferative and proapoptotic effects of 3,3'-...

    journal_title:Cancer research

    pub_type: 杂志文章,收录出版

    doi:10.1158/0008-5472.CAN-06-2011

    authors: Bhuiyan MM,Li Y,Banerjee S,Ahmed F,Wang Z,Ali S,Sarkar FH

    更新日期:2006-10-15 00:00:00

  • Interaction of monoclonal antibodies with cell surface antigens of human ovarian carcinomas.

    abstract::Two monoclonal antibodies, OC 125 and OC 133, bind to distinct determinants on the surface of human epithelial ovarian carcinoma cell lines. OC 125 and OC 133 recognize determinants on molecules with molecular weights greater than 200,000 and 80,000, respectively. When binding to four different cell lines was compared...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Masuho Y,Zalutsky M,Knapp RC,Bast RC Jr

    更新日期:1984-07-01 00:00:00